About GHESKIO
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at GHESKIO
During the past decade, GHESKIO conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on
average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
1989-09-01
Active, not recruiting
615
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
1993-11-01
Unknown status
1,520
Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
1994-12-01
Completed
640
Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
1995-08-01
Completed
392
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
1995-10-01
Unknown status
750
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
1995-02-01
Completed
3,300
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
1996-12-01
Unknown status
80
Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome
1998-08-01
Unknown status
50
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "GHESKIO"
#1 collaborator was "Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic" with 6 trials as a collaborator, "Analysis Group, Inc." with 3 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "Weill Medical College of Cornell University" with 3 trials as a collaborator and "Florida International University" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at GHESKIO
According to Clinical.Site data, the most researched conditions in "GHESKIO" are
"HIV" (3 trials), "HIV/AIDS" (3 trials), "HIV Infection" (2 trials), "Antiretroviral Therapy" (1 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "GHESKIO" in a lesser frequency.
Clinical Trials Intervention Types at GHESKIO
Most popular intervention types in "GHESKIO" are "Drug" (4 trials), "Behavioral" (2 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amlodipine 5mg" (1 trials), "B/F/TAF" (1 trials), "Bedaquiline" (1 trials), "Clofazimine" (1 trials) and "Cohort 1" (1 trials). Other intervention names were less common.
Clinical Trials Genders at GHESKIO
The vast majority of trials in "GHESKIO" are
7 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at GHESKIO
Currently, there are NaN active trials in "GHESKIO".
1 are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in GHESKIO,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in GHESKIO, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 4 trials that are defined as “Not Applicable".